These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22749329)

  • 1. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.
    Moruf A; Spyropoulos AC; Schardt TQ; Gibson E; Manco-Johnson MJ; Wang M; Goldenberg NA
    Thromb Res; 2012 Oct; 130(4):612-5. PubMed ID: 22749329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
    Lee AY; Bauersachs R; Janas MS; Jarner MF; Kamphuisen PW; Meyer G; Khorana AA;
    BMC Cancer; 2013 Jun; 13():284. PubMed ID: 23764005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants.
    Uppuluri EM; Burke KR; Haaf CM; Shapiro NL
    J Oncol Pharm Pract; 2019 Mar; 25(2):261-268. PubMed ID: 28942721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in lymphoma: how effectively are we treating patients?
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
    Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-procedural antithrombotic management: time to burn the bridge?
    Marquez J; Togami JC; Dant CR; Herrera A; Marshik P; Burnett AE
    J Thromb Thrombolysis; 2018 Apr; 45(3):337-344. PubMed ID: 29383558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMWH in cancer patients with renal impairment - better than warfarin?
    Bauersachs RM
    Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
    Thachil J
    Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
    Attaya H; Wysokinski WE; Bower T; Litin S; Daniels PR; Slusser J; Heit JA; McBane RD
    J Thromb Thrombolysis; 2013 Jan; 35(1):100-6. PubMed ID: 22843195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis.
    Lee MC; Liao CT; Feng IJ; Yu T; Chang WT; Shih MF; Su HC; Toh HS
    Medicine (Baltimore); 2022 Sep; 101(37):e30412. PubMed ID: 36123930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry-based cohort study.
    Barnes GD; Li Y; Gu X; Haymart B; Kline-Rogers E; Ali MA; Kozlowski J; Krol G; Froehlich JB; Kaatz S
    J Thromb Haemost; 2020 Aug; 18(8):2025-2030. PubMed ID: 32428998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.